慢性心力衰竭气虚血瘀证应用益气活血方治疗的临床疗效观察  被引量:2

Effective observation on treating chronic heart failure of the Qi deficiency and blood stasis syndrome with prescription for benefiting Qi and activating blood circulation

在线阅读下载全文

作  者:刘湘杰 刘思弘 LIU Xiangjie

机构地区:[1]衡阳市中医医院,湖南衡阳421001 [2]衡阳市第三人民医院,湖南衡阳421001

出  处:《中医临床研究》2022年第14期99-101,共3页Clinical Journal Of Chinese Medicine

摘  要:目的:观察慢性心力衰竭气虚血瘀证患者应用益气活血方治疗的临床疗效。方法:筛选2018年12月-2019年12月衡阳市中医医院诊治的130例气虚血瘀证慢性心力衰竭患者,将患者随机分为两组,治疗组65例在常规抗心力衰竭西药治疗的基础上加服中药益气活血方治疗;对照组65例仅采用常规抗心力衰竭西药治疗。对比用药前后患者心功能相关指标、西药停减率和中医证候积分。结果:治疗组在用药后的左室收缩末期内径、左室射血分数水平、N端脑钠肽前体水平改善均优于对照组,P <0.05;治疗组与对照组相比西药停减率更高,P <0.05;治疗组用药后的中医证候积分低于对照组,P <0.05。结论:益气活血方对慢性心力衰竭气虚血瘀证患者的临床疗效显著,有利于减轻临床症状,提高治疗效果,对机体功能进行改善。Objective:To observe the clinical efficacy of prescription for benefiting Qi(气)and activating blood circulation on chronic heart failure patients with the Qi deficiency and blood stasis syndrome.Methods:From December 2018 to December 2019,and 130 patients were randomly divided into two groups.Sixty-five cases in the treatment group were treated prescription for benefiting Qi and activating blood circulation plus conventional anti-heart failure Western medicine.Sixty-five cases in the control group were only treated with conventional anti-heart failure Western medicine.Results:Left ventricular end-systolic diameter,left ventricular ejection fraction,and N-terminal brain natriuretic peptide precursor in the treatment group were better than those in the control group,P<0.05;the TCM syndrome score in the treatment group was lower than that in the control group,P<0.05.Conclusion:Prescription for benefiting Qi activating blood circulation has a significant clinical effect on chronic heart failure patients with the Qi deficiency and blood stasis syndrome,can relieve clinical symptoms,and improve body function.

关 键 词:慢性心力衰竭 气虚血瘀证 中西医结合 

分 类 号:R256.2[医药卫生—中医内科学]

 

参考文献:

正在载入数据...

 

二级参考文献:

正在载入数据...

 

耦合文献:

正在载入数据...

 

引证文献:

正在载入数据...

 

二级引证文献:

正在载入数据...

 

同被引文献:

正在载入数据...

 

相关期刊文献:

正在载入数据...

相关的主题
相关的作者对象
相关的机构对象